Antidiabetic potential of two novel fatty acaid derivatised, N-terminally modified analogues of glucose-dependent insulinotropic polypeptide (GIP): N-AcGIP(LysPAL16) and N-AcGIP(LysPAL37).

Autoria(s): Harriott, Patrick; Irwin, N.; Gault, V.A.; Green, B.D.; Greer, Brett
Data(s)

2005
Identificador

http://pure.qub.ac.uk/portal/en/publications/antidiabetic-potential-of-two-novel-fatty-acaid-derivatised-nterminally-modified-analogues-of-glucosedependent-insulinotropic-polypeptide-gip-nacgiplyspal16-and-nacgiplyspal37(04a3ef16-6f76-4de3-a5af-13404d5d374e).html
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Harriott , P , Irwin , N , Gault , V A , Green , B D & Greer , B 2005 , ' Antidiabetic potential of two novel fatty acaid derivatised, N-terminally modified analogues of glucose-dependent insulinotropic polypeptide (GIP): N-AcGIP(LysPAL16) and N-AcGIP(LysPAL37). ' Biological Chemistry , vol 386 , pp. 679-687 .
Tipo

article
Acesso ao item digital